NASDAQ: XRXXerox Holdings Corp Stock
$13.95-0.07 (-0.5%)
Updated May 17, 2024
XRX Price
$13.95
Fair Value Price
$38.04
Market Cap
$1.73B
52 Week Low
$12.06
52 Week High
$19.78
P/E
-9.55x
P/B
0.73x
P/S
0.33x
PEG
N/A
Dividend Yield
3.58%
Revenue
$6.67B
Earnings
-$183.00M
Gross Margin
32.5%
Operating Margin
-3.94%
Profit Margin
-3%
Debt to Equity
3.09
Operating Cash Flow
$529M
Beta
1.25
Next Earnings
May 22, 2024
Ex-Dividend
N/A
Next Dividend
N/A
XRX Overview
Xerox Holdings Corporation sells document management systems the U.S.and internationally. It offers workplace solutions, including photocopiers, desktop printers, and digital printing presses. The company also provides graphics production solutions, IT services, and end-user computing devices. Xerox was founded in 1906 and is headquartered in Norwalk, CT.
Zen Score
–
Industry Average (34)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how XRX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XRX ($13.95) is undervalued by 63.33% relative to our estimate of its Fair Value price of $38.04 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
XRX ($13.95) is significantly undervalued by 63.33% relative to our estimate of its Fair Value price of $38.04 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
XRX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more XRX due diligence checks available for Premium users.
Be the first to know about important XRX news, forecast changes, insider trades & much more!
XRX News
Valuation
XRX fair value
Fair Value of XRX stock based on Discounted Cash Flow (DCF)
Price
$13.95
Fair Value
$38.04
Undervalued by
63.33%
XRX ($13.95) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
XRX ($13.95) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
XRX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
XRX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-9.55x
Industry
27.32x
Market
30.97x
XRX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.73x
Industry
4.56x
XRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
XRX's financial health
Profit margin
Revenue
$1.5B
Net Income
-$113.0M
Profit Margin
-7.8%
XRX's Earnings (EBIT) of -$263.00M... subscribe to Premium to read more.
Interest Coverage Financials
XRX's profit margin (-3%) has... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$9.9B
Liabilities
$7.3B
Debt to equity
3.09
XRX's short-term assets ($3.35B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XRX's long-term liabilities ($4.90B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XRX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
XRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$79.0M
Investing
-$17.0M
Financing
$261.0M
XRX's operating cash flow ($529.00M)... subscribe to Premium to read more.
Debt Coverage Financials
XRX vs Information Technology Service Stocks
Xerox Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.